OptiNose Inc OPTN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/12/22 EDT
3.76UNCH (UNCH)
Volume
633
Close
3.76quote price arrow up+0.17 (+4.74%)
Volume
251,860
52 week range
1.46 - 4.14
Loading...
  • Open3.52
  • Day High3.82
  • Day Low3.52
  • Prev Close3.59
  • 52 Week High4.14
  • 52 Week High Date07/07/22
  • 52 Week Low1.46
  • 52 Week Low Date12/02/21

Key Stats

  • Market Cap310.88M
  • Shares Out82.68M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta-0.08
  • YTD % Change132.1

KEY STATS

  • Open3.52
  • Day High3.82
  • Day Low3.52
  • Prev Close3.59
  • 52 Week High4.14
  • 52 Week High Date07/07/22
  • 52 Week Low1.46
  • 52 Week Low Date12/02/21
  • Market Cap310.88M
  • Shares Out82.68M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta-0.08
  • YTD % Change132.1

RATIOS/PROFITABILITY

  • EPS (TTM)-1.30
  • P/E (TTM)-2.89
  • Fwd P/E (NTM)-4.84
  • EBITDA (TTM)-65.055M
  • ROE (TTM)-1,050.50%
  • Revenue (TTM)77.45M
  • Gross Margin (TTM)87.83%
  • Net Margin (TTM)-105.32%
  • Debt To Equity (MRQ)-283.01%

EVENTS

  • Earnings Date11/14/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On OptiNose Inc

There is no recent news for this security.

Profile

MORE
OptiNose, Inc. is a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists. The Company's first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 micrograms (mcg), is a therapeutic utilizing the Company's Exhalation Delivery System (EDS), which delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal...
Joseph Scodari
Independent Chairman of the Board
Peter Miller
Chief Executive Officer, Director
Ramy Mahmoud M.D.
President, Chief Operating Officer
Michele Janis
Acting Chief Financial Officer
Anthony Krick
Chief Accounting Officer
Address
1020 Stony Hill Rd Ste 300
Yardley, PA
19067-5539
United States

Top Peers

SYMBOLLASTCHG%CHG
ESPR
Esperion Therapeutics Inc
6.70+0.06+0.90%
HROW
Harrow Health Inc
8.50-0.04-0.47%
OMER
Omeros Corp
7.13-0.07-0.97%
EYPT
EyePoint Pharmaceuticals Inc
11.11+0.02+0.18%
OCUL
Ocular Therapeutix Inc
5.48+0.02+0.37%